July 22, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 17.36% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic products. Based..

Addus HomeCare Corporation (ADUS) Stock Analysis: 27% Upside Potential Amid Robust Revenue Growth

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, stands out with its promising financial metrics and growth prospects. With a market capitalization..

Ligand Pharmaceuticals (LGND): Investor Outlook on a Biotech Leader with a 46% Revenue Growth Surge

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, stands out with its robust portfolio of biopharmaceutical assets. The company, headquartered in Jupiter,..

Amedisys Inc (AMED) Stock Analysis: Navigating Valuation Metrics and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED), a prominent player in the healthcare sector, operates in the medical care facilities industry, specializing in providing crucial home health, hospice, and..

Astrana Health Inc. (ASTH) Stock Analysis: A 105% Upside Potential Amidst Robust Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company headquartered in Alhambra, California, is emerging as a compelling investment opportunity within the medical care facilities industry...

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Landscape with a 7.73% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is a key player in the burgeoning virtual healthcare sector, offering a range of integrated care solutions and mental health services..

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 35% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is commanding attention with a..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating High Growth in Biotechnology with Significant Challenges

Ascentage Pharma Group International (NASDAQ: AAPG), a prominent player in the biotechnology sector, is making waves with its ambitious pipeline targeting cancers, chronic hepatitis B, and..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a 3.36% Potential Upside Amidst Healthcare Sector Dynamics

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates senior living communities across the United States. With a market capitalization of..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A Biotech with 182.60% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has captured investor attention with its promising drug pipeline and significant upside potential. The company, based in..

PACS Group, Inc. (PACS) Stock Analysis: A 162% Upside Potential in Healthcare

PACS Group, Inc. (NASDAQ: PACS), a prominent player in the healthcare sector, is catching the eye of investors with a staggering potential upside of 162.48%. Operating..

Indivior PLC (INDV) Stock Analysis: Exploring a 23.4% Upside Potential in the Healthcare Sector

Indivior PLC (INDV), a notable player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry, presents an intriguing opportunity for investors seeking..

Merus N.V. (MRUS) Stock Analysis: Strong Buy Ratings and Promising 44% Upside Potential

Merus N.V. (NASDAQ: MRUS) is gaining attention in the biotechnology sector with its promising pipeline of bispecific antibody therapeutics. Based in the Netherlands, this clinical-stage immuno-oncology..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: 48.55% Potential Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (AMRX) presents a compelling case with a potential upside of 48.55%, according to recent analyst..

James Cropper sets cash-first plan as Advanced Materials targets growth (LON:CRPR)

CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m..

BGM Group Ltd. (BGM): Investor Outlook Amidst a Challenging Revenue Landscape in the Healthcare Sector

BGM Group Ltd. (BGM), a key player in the healthcare sector specializing in drug manufacturing, is navigating a complex market environment. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unveiling the 132% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical innovator, is making waves in the biotechnology sector with its ambitious focus on neurodegenerative and lysosomal storage diseases. Despite..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Significant Upside Potential Amidst Innovative Genetic Medicines Development

Beam Therapeutics Inc. (NASDAQ: BEAM) is steadily carving out its niche in the biotechnology sector with its focus on precision genetic medicines. As the company continues..

Clover Health Investments (CLOV): Analyzing the 50% Upside Potential in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) is steadily carving a niche in the healthcare sector, focusing primarily on Medicare Advantage plans in the United States. Based..

Immunovant, Inc. (IMVT) Stock Analysis: Seizing a 145% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a dynamic player in the biotechnology sector, has been making waves with its ambitious pursuits in the field of autoimmune therapies. As..

Search

Funds

July 22, 2025

James Cropper sets cash-first plan as Advanced Materials targets growth (LON:CRPR)

CEO David Stirling and CFO Andrew Goody report FY to 29 March 2025: revenue just under £100m, EBITDA just under £7m, net debt down nearly £3m to below 2x EBITDA...
Search

Funds

July 22, 2025

FTSE 100

Funds